Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain.
Behav Brain Res
; 320: 282-290, 2017 03 01.
Article
en En
| MEDLINE
| ID: mdl-27993694
ABSTRACT
Methamphetamine (MA) studies in animals usually involve acute, binge, or short-term exposure to the drug. However, addicts take substantial amounts of MA for extended periods of time. Here we wished to study the effects of MA exposure on brain and behavior, using an animal model analogous to this pattern of MA intake. MA doses, 4 and 8mg/kg/day, were based on previously reported average daily freely available MA self-administration levels. We examined the effects of 16 week MA treatment on psychomotor and cognitive function in the rat using open field and novel object recognition tests and we studied the adaptations of the dopaminergic system, using in vitro and in vivo receptor imaging. We show that chronic MA treatment, at doses that correspond to the average daily freely available self-administration levels in the rat, disorganizes open field activity, impairs alert exploratory behavior and anxiety-like state, and downregulates dopamine transporter in the striatum. Under these treatment conditions, dopamine terminal functional integrity in the nucleus accumbens is also affected. In addition, lower dopamine D1 receptor binding density, and, to a smaller degree, lower dopamine D2 receptor binding density were observed. Potential mechanisms related to these alterations are discussed.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Desempeño Psicomotor
/
Encéfalo
/
Transducción de Señal
/
Dopamina
/
Cognición
/
Estimulantes del Sistema Nervioso Central
/
Metanfetamina
Idioma:
En
Revista:
Behav Brain Res
Año:
2017
Tipo del documento:
Article